Gorjan Hrustanovic's most recent trade in Kymera Therapeutics Inc was a trade of 16,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kymera Therapeutics Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 24,150 | 24,150 | - | - | Stock Option (right to buy) | |
| Kymera Therapeutics Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (right to buy) | |
| Olema Pharmaceuticals Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Kymera Therapeutics Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Kymera Therapeutics Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Rain Oncology Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 20,063 | 20,063 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Olema Pharmaceuticals Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2020 | 21,520 | 21,520 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2020 | 21,520 | 21,520 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2020 | 21,520 | 21,520 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Gorjan Hrustanovic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2020 | 40,127 | 40,127 | - | - | Stock Option (Right to Buy) |